[Treatment for de novo chronic myeloid leukemia in chronic phase]

Nihon Rinsho. 2012 Apr:70 Suppl 2:298-303.

[Article in Japanese]

Authors

Chikara Hirase¹, Itaru Matsumura

Affiliation

¹ Division of Hematology and Rheumatology, Department of Internal Medicine, Kinki University Faculty of Medicine.

PMID: 23133971

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use*
Benzamides
Dasatinib
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Piperazines / therapeutic use*
Protein-Tyrosine Kinases / antagonists & inhibitors
Pyrimidines / therapeutic use*
Thiazoles / therapeutic use

Substances

Antineoplastic Agents
Benzamides
Piperazines
Pyrimidines
Thiazoles
Imatinib Mesylate
Protein-Tyrosine Kinases
nilotinib
Dasatinib